Cover Image
Market Research Report

Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal, End User - Global Forecast to 2024

Published by MarketsandMarkets Product code 829738
Published Content info 279 Pages
Delivery time: 1-2 business days
Price
Back to Top
Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal, End User - Global Forecast to 2024
Published: April 29, 2019 Content info: 279 Pages
Description

"The companion animal diagnostics market is projected to reach USD 2.7 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 9.8%."

The rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed economies are the major factors that are driving the growth of the global companion animal diagnostics market. The growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years. However, the increasing pet care costs are expected to restrain market growth to a certain extent.

Companion animal diagnostics market for dogs to grow at the highest CAGR during the forecast period

Based on animal type, the companion animal diagnostics market is segmented into dogs, cats, horses, and other companion animals. The dogs segment is expected to grow at the highest CAGR during the forecast period majorly due to the growing dog ownership, increasing prevalence of infectious and zoonotic diseases, growing occurrence of skin allergies in dogs, rising healthcare expenditure for dogs, and the growing penetration of pet health insurance.

Point-of-care/in-house testing segment to witness the highest growth during the forecast period

Based on end user, the companion animal diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes and universities. The point-of-care/in-house testing segment is estimated to grow at the highest CAGR during the forecast period owing to the advantages of POC/in-house testing, including ease of use and accurate, real-time results.

Asia Pacific market to witness the highest growth during the forecast period

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the growing adoption of companion animals, increasing awareness about pet healthcare and zoonotic diseases, and the growing number of veterinary hospitals and clinics in several APAC countries.

Breakdown of Primary Participants from the Supply Side:

  • By Company Type - Tier 1-35%, Tier 2-40%, and Tier 3-25%
  • By Designation - C Level-25%, Director Level-30%, and Others-45%
  • By Region - North America-30%, Europe-35%, Asia Pacific-15%, Latin America- 10%, and Middle East and Africa-10%

Some of the major players operating in the companion animal diagnostics market are: IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), Heska Corporation (US), Neogen Corporation (US), bioMerieux SA (France), IDvet (France), INDICAL Bioscience GmbH (Germany) [QIAGEN N.V. (Netherlands)], and Randox Laboratories Ltd. (UK).

Research Coverage:

This report analyzes the companion animal diagnostics market and aims at estimating the size and future growth potential of this market based on various segments, namely, technology, application, animal type, end user, and region. The report also includes a product portfolio matrix of the companion animal diagnostic products available in the market. The competitive leadership mapping provided in this report helps analyze the position of market players as visionary leaders, innovators, dynamic players, and emerging players. A comprehensive competitive analysis of key players in this market, along with their company profiles, product offerings, recent developments, and key growth strategies, has also been provided in this report.

Reasons to Buy the Report:

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global companion animal diagnostics market. The report analyzes this market by technology, application, animal type, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global companion animal diagnostics market.
  • Market Development: Comprehensive information on the lucrative emerging markets by technology, application, animal type, end user, and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global companion animal diagnostics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global companion animal diagnostics market.
Table of Contents
Product Code: MD 7053

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 SCOPE OF THE STUDY
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY SOURCES
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY SOURCES
      • 2.1.2.1 Primary sources
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 COMPANION ANIMAL DIAGNOSTICS: MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, 2018
  • 4.3 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC MIX
  • 4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS: IMPACT ANALYSIS
  • 5.3 KEY MARKET DRIVERS
    • 5.3.1 GROWTH IN THE COMPANION ANIMAL POPULATION
    • 5.3.2 RISING DEMAND FOR PET INSURANCE
    • 5.3.3 GROWTH IN THE NUMBER OF VETERINARY PRACTITIONERS IN DEVELOPED ECONOMIES
  • 5.4 KEY MARKET RESTRAINTS
    • 5.4.1 INCREASING PET CARE COSTS
  • 5.5 KEY MARKET OPPORTUNITIES
    • 5.5.1 GROWING DEMAND FOR RAPID TESTS & PORTABLE INSTRUMENTS FOR POINT-OF-CARE (POC) DIAGNOSTIC SERVICES
  • 5.6 KEY CHALLENGES
    • 5.6.1 LACK OF ANIMAL HEALTHCARE AWARENESS IN EMERGING MARKETS
    • 5.6.2 SHORTAGE OF VETERINARIANS IN EMERGING MARKETS

6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
  • 6.2 CLINICAL BIOCHEMISTRY
    • 6.2.1 CLINICAL CHEMISTRY ANALYSIS
      • 6.2.1.1 Reagent clips and cartridges
        • 6.2.1.1.1 Reagent clips and cartridges accounted for the largest share of the clinical chemistry analysis market
      • 6.2.1.2 Analyzers
        • 6.2.1.2.1 Clinical chemistry analyzers have wide applications in veterinary hospitals, reference laboratories, small clinics, and research institutes
    • 6.2.2 GLUCOSE MONITORING
      • 6.2.2.1 Blood glucose strips
        • 6.2.2.1.1 Blood glucose strips segment accounted for the largest share of the glucose monitoring market in 2018
      • 6.2.2.2 Glucose monitors
        • 6.2.2.2.1 The use of glucose monitors helps in making diagnostic and therapeutic decisions in a relatively inexpensive manner
      • 6.2.2.3 Urine glucose strips
        • 6.2.2.3.1 Urine glucose strips are used to measure glucose and ketone concentrations in urine
    • 6.2.3 BLOOD GAS ELECTROLYTE ANALYSIS
      • 6.2.3.1 Reagent clips and cartridges
        • 6.2.3.1.1 Reagent clips and cartridges segment commanded the largest share of the blood gas electrolyte analysis market in 2018
      • 6.2.3.2 Analyzers
        • 6.2.3.2.1 Blood gas electrolyte analyzers are used to determine blood pH and the amount of oxygen and carbon dioxide in the blood
  • 6.3 IMMUNODIAGNOSTICS
    • 6.3.1 LATERAL FLOW ASSAYS
      • 6.3.1.1 Rapid tests
        • 6.3.1.1.1 Rising prevalence of infectious diseases to drive the adoption of lateral flow rapid tests
      • 6.3.1.2 Strip readers
        • 6.3.1.2.1 Lateral flow strip readers are not frequently used by veterinary practitioners
    • 6.3.2 ELISA TESTS
      • 6.3.2.1 ELISA tests segment to register the highest growth rate during the forecast period
    • 6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
      • 6.3.3.1 Growing number of allergy cases in pets to drive market growth
    • 6.3.4 IMMUNOASSAY ANALYZERS
      • 6.3.4.1 Large number of samples can be loaded into immunoassay analyzers to determine the results of immunoassay tests
    • 6.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
  • 6.4 HEMATOLOGY
    • 6.4.1 CARTRIDGES
      • 6.4.1.1 Hematology cartridges are used to measure the hematocrit and hemoglobin level in animal blood samples
    • 6.4.2 ANALYZERS
      • 6.4.2.1 Hematology analyzers are used to measure blood cell counts and the coagulation time of blood
  • 6.5 URINALYSIS
    • 6.5.1 URINALYSIS CLIPS AND CARTRIDGES/PANELS
      • 6.5.1.1 Urinalysis clips and cartridges/panels are used to measure multiple electrolytes and metabolites for the detection of kidney diseases, urinary tract infections, and diabetes
    • 6.5.2 URINE ANALYZERS
      • 6.5.2.1 Technological innovations to drive market growth
    • 6.5.3 URINE TEST STRIPS
      • 6.5.3.1 Urine test strips are used for the qualitative evaluation of urine parameters
  • 6.6 MOLECULAR DIAGNOSTICS
    • 6.6.1 POLYMERASE CHAIN REACTION (PCR) TESTS
      • 6.6.1.1 PCR testing identifies a pathogen based on the presence of the pathogen's DNA or RNA in the patient specimen, before antibody can be detected, making it a useful diagnostic tool for early disease detection in sick animals
    • 6.6.2 MICROARRAYS
      • 6.6.2.1 Increased speed and accuracy of screening and confirmation are driving the use of microarrays in the diagnosis of various therapeutic conditions in companion animals
    • 6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
  • 6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES

7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CLINICAL PATHOLOGY
    • 7.2.1 CLINICAL PATHOLOGY DOMINATES THE COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
  • 7.3 BACTERIOLOGY
    • 7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE THE MARKET FOR BACTERIOLOGY
  • 7.4 VIROLOGY
    • 7.4.1 RISING NUMBER OF VIRAL OUTBREAKS ARE CONTRIBUTING TO MARKET GROWTH IN THIS SEGMENT
  • 7.5 PARASITOLOGY
    • 7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT THE GROWTH OF THIS APPLICATION SEGMENT
  • 7.6 OTHER APPLICATIONS

8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 DOGS
    • 8.2.1 INCREASE IN THE DOG POPULATION AND THEIR OWNERSHIP RATE-KEY GROWTH DRIVER FOR THIS SEGMENT
  • 8.3 CATS
    • 8.3.1 GROWING RESEARCH ON THE HEALTHCARE AND WELLBEING OF CATS TO SUPPORT THE GROWTH OF THIS SEGMENT
  • 8.4 HORSES
    • 8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH
  • 8.5 OTHER COMPANION ANIMALS

9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 REFERENCE LABORATORIES
    • 9.2.1 REFERENCE LABS RECEIVE LARGE NUMBERS OF SAMPLES FROM VETERINARY PRACTICES
  • 9.3 VETERINARY HOSPITALS & CLINICS
    • 9.3.1 HOSPITALS & CLINICS ARE THE FIRST POINT OF CONTACT FOR PET OWNERS
  • 9.4 POINT-OF-CARE/IN-HOUSE TESTING
    • 9.4.1 NEED TO IMPROVE CARE AND REDUCE COSTS HAS DRIVEN THE ADOPTION OF POC DIAGNOSTICS
  • 9.5 RESEARCH INSTITUTES & UNIVERSITIES
    • 9.5.1 INDUSTRY-ACADEMIA COLLABORATION HAS GROWN IN RECENT YEARS

10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 US dominates the companion animal diagnostics market in North America
    • 10.2.2 CANADA
      • 10.2.2.1 Awareness of pet health has risen in Canada
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany is the largest market for companion animal diagnostics in Europe
    • 10.3.2 UK
      • 10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases promoted by regulatory authorities to drive the UK market
    • 10.3.3 FRANCE
      • 10.3.3.1 Technological expertise and innovations attract market players to compete in the companion animal diagnostics market in France
    • 10.3.4 ITALY
      • 10.3.4.1 Increased pet adoption, along with better availability of pet products through large-scale outlets, is supporting market growth in Italy
    • 10.3.5 SPAIN
      • 10.3.5.1 Rising animal health expenditure and the growing number of veterinary facilities to drive the growth of this market
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 China dominates the Asia Pacific companion animal diagnostics market
    • 10.4.2 JAPAN
      • 10.4.2.1 Rising demand for imported pet breeds is expected to drive the companion animal diagnostics market in Japan
    • 10.4.3 INDIA
      • 10.4.3.1 India is an untapped market with huge growth potential
    • 10.4.4 REST OF APAC
  • 10.5 LATIN AMERICA
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil has the third-largest pet population country in the world
    • 10.5.2 MEXICO
      • 10.5.2.1 Mexico is the second-largest pet care market in Latin America
    • 10.5.3 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 RELUCTANCE TO SPEND ON PET HEALTH HAS SLOWED PACE OF MARKET GROWTH

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 GROWTH STRATEGY MATRIX
  • 11.3 MARKET SHARE ANALYSIS (2018)
  • 11.4 COMPETITIVE LEADERSHIP MAPPING
    • 11.4.1 VISIONARY LEADERS
    • 11.4.2 INNOVATORS
    • 11.4.3 DYNAMIC DIFFERENTIATORS
    • 11.4.4 EMERGING COMPANIES
  • 11.5 COMPETITIVE SITUATION AND TRENDS
    • 11.5.1 PRODUCT LAUNCHES
    • 11.5.2 ACQUISITIONS
    • 11.5.3 PARTNERSHIPS
    • 11.5.4 EXPANSIONS

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 12.1 IDEXX LABORATORIES, INC.
  • 12.2 ZOETIS INC.
  • 12.3 THERMO FISHER SCIENTIFIC INC.
  • 12.4 VIRBAC
  • 12.5 HESKA CORPORATION
  • 12.6 NEOGEN CORPORATION
  • 12.7 BIOMERIEUX SA
  • 12.8 INDICAL BIOSCIENCE GMBH (QIAGEN N.V.)
  • 12.9 IDVET
  • 12.10 RANDOX LABORATORIES, LTD.

Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS OF INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: STANDARD CURRENCY CONVERSION RATES
  • TABLE 2: NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012-2016) (USD MILLION)
  • TABLE 3: DEVELOPED ECONOMIES: NUMBER OF VETERINARY PROFESSIONALS (2012-2017)
  • TABLE 4: NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY
  • TABLE 5: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 6: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 8: CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 10: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 11: CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 15: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 16: GLUCOSE MONITORING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: GLUCOSE MONITORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 21: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: BLOOD GAS ELECTROLYTE REAGENT CLIPS AND CARTRIDGES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23: BLOOD GAS ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24: KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 25: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 26: IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 28: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29: LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: ELISA TESTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32: ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: KEY HEMATOLOGY PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 36: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 37: HEMATOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: KEY URINALYSIS PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 41: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 42: URINALYSIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: URINALYSIS CLIPS AND CARTRIDGES/PANELS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: URINE ANALYZERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: URINE TEST STRIPS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 47: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: PCR TESTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: MICROARRAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 50: OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 53: COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56: COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 57: COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: COMPANION ANIMAL POPULATION (2014-2017) (MILLION)
  • TABLE 59: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: HORSE POPULATION, BY REGION, 2014-2017 (MILLION)
  • TABLE 63: COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: OTHER COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 65: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 66: COMPANION ANIMAL DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, 2017-2024 (USD MILLION)
  • TABLE 67: VETERINARY VISIT EXPENSES FOR CATS AND DOGS IN THE US
  • TABLE 68: COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS AND CLINICS, 2017-2024 (USD MILLION)
  • TABLE 69: COMPANION ANIMAL DIAGNOSTICS MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, 2017-2024 (USD MILLION)
  • TABLE 70: COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES AND UNIVERSITIES, 2017-2024 (USD MILLION)
  • TABLE 71: COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 72: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 73: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 74: NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 76: NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 77: NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 78: NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 79: NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 80: NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 81: NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 82: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 85: US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2012 VS. 2017
  • TABLE 86: US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 87: US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 88: US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 89: US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 90: US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 91: US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 92: US: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 93: US: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 94: US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 95: US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 97: US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 98: COMPANION ANIMAL POPULATION IN CANADA, 2014 VS. 2016 (MILLION)
  • TABLE 99: CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 100: CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 102: CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 103: CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 104: CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 105: CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 106: CANADA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 107: CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 108: CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 110: CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 111: EUROPE: NUMBER OF VETERINARIANS, 2012-2016
  • TABLE 112: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 113: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 114: EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 116: EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 117: EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 118: EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 119: EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 120: EUROPE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 121: EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 122: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 124: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 125: GERMANY: COMPANION ANIMAL POPULATION, 2010-2017 (MILLION)
  • TABLE 126: GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 127: GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 128: GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 130: GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 131: GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 132: GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 133: GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 134: GERMANY: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 135: GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 136: GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 137: GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 138: GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 139: UK: COMPANION ANIMAL POPULATION (2010-2014) (MILLION)
  • TABLE 140: UK: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 141: UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 142: UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143: UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 144: UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 145: UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 146: UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 147: UK: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 148: UK: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 149: UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 150: UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 151: UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 152: UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 153: FRANCE: COMPANION ANIMAL POPULATION, 2010-2017 (MILLION)
  • TABLE 154: FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016
  • TABLE 155: FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 156: FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 157: FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 158: FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 159: FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 160: FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 161: FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 162: FRANCE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 163: FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 164: FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 166: FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 167: ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2016
  • TABLE 168: ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 169: ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 170: ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 171: ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 172: ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 173: ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 174: ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 175: ITALY: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 176: ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 177: ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 178: ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 179: ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 180: SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 181: SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 182: SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 183: SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 184: SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 185: SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 186: SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 187: SPAIN: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 188: SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 189: SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 190: SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 191: SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 192: COMPANION ANIMAL OWNERSHIP IN THE REST OF EUROPE, 2017 (MILLION)
  • TABLE 193: ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 194: ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 195: ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 196: ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 197: ROE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 198: ROE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 199: ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 200: ROE: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 201: ROE: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 202: ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 203: ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 204: ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 205: ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 206: APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 207: APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 208: APAC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 209: APAC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 210: APAC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 211: APAC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 212: APAC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 213: APAC: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 214: APAC: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 215: APAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 216: APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 217: APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 218: APAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 219: CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 220: CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 221: CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 222: CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 223: CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 224: CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 225: CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 226: CHINA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 227: CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 228: CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD
  • TABLE 229: CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 230: CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 231: JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 232: JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 233: JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 234: JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 235: JAPAN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 236: JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 237: JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 238: JAPAN: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 239: JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 240: JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 241: JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 242: JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 243: INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 244: INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 245: INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 246: INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 247: INDIA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 248: INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 249: INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 250: INDIA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 251: INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 252: INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 253: INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 254: INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 255: ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 256: ROAPAC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 257: ROAPAC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 258: ROAPAC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 259: ROAPAC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 260: ROAPAC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 261: ROAPAC: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 262: ROAPAC: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 263: ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 264: ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 265: ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 266: ROAPAC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 267: LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 268: LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 269: LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 270: LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 271: LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 272: LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 273: LATIN AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 274: LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 275: LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 276: LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 277: LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 278: LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 279: LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 280: LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 281: BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 282: BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 283: BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 284: BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 285: BRAZIL: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 286: BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 287: BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 288: BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 289: BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 290: BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 291: BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 292: BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 293: MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 294: MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 295: MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 296: MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 297: MEXICO: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 298: MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 299: MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 300: MEXICO: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 301: MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 302: MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 303: MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 304: MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 305: ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 306: ROLATAM: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 307: ROLATAM: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 308: ROLATAM: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 309: ROLATAM: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 310: ROLATAM: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 311: ROLATAM: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 312: ROLATAM: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 313: ROLATAM: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 314: ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 315: ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 316: ROLATAM: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 317: MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 318: AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS (2010 VS. 2016)
  • TABLE 319: MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
  • TABLE 320: MEA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 321: MEA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 322: MEA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 323: MEA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 324: MEA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 325: MEA: HEMATOLOGY MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 326: MEA: URINALYSIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 327: MEA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 328: MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 329: MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 330: MEA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 331: PRODUCT LAUNCHES (JANUARY 2015-FEBRUARY 2019)
  • TABLE 332: ACQUISITIONS ( JANUARY 2015- FEBRUARY 2019)
  • TABLE 333: PARTNERSHIPS (JANUARY 2015- FEBRUARY 2019)
  • TABLE 334: EXPANSIONS (JANUARY 2015- FEBRUARY 2019)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 12: GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: CHINA HOLDS THE LARGEST SHARE OF THE APAC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2018
  • FIGURE 14: CHINA AND INDIA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 15: NORTH AMERICA WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL DIAGNOSTICS MARKET BY 2024
  • FIGURE 16: DEVELOPING MARKETS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: DEVELOPED COUNTRIES: PET POPULATION & PET OWNERSHIP
  • FIGURE 18: US: PET INDUSTRY EXPENDITURE
  • FIGURE 19: COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 20: CLINICAL PATHOLOGY WILL CONTINUE TO DOMINATE THE COMPANION ANIMAL DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
  • FIGURE 22: GEOGRAPHIC SNAPSHOT (2018): US ACCOUNTED FOR THE LARGEST SHARE OF THE COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 23: NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 24: US: PET OWNERSHIP INDICATORS, 2017
  • FIGURE 25: EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 26: ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 27: KEY DEVELOPMENTS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET BETWEEN JANUARY 2015 AND FEBRUARY 2019
  • FIGURE 28: COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 29: IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 30: ZOETIS INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 31: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 32: VIRBAC: COMPANY SNAPSHOT (2017)
  • FIGURE 33: HESKA CORPORATION: COMPANY SNAPSHOT(2018)
  • FIGURE 34: NEOGEN CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 35: BIOMERIEUX SA: COMPANY SNAPSHOT (2018)
  • FIGURE 36: QIAGEN N.V.: COMPANY SNAPSHOT (2018)
Back to Top